Dolby Laboratories (NYSE:DLB – Get Free Report) had its target price decreased by research analysts at Rosenblatt Securities from $85.00 to $80.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the electronics maker’s stock. Rosenblatt Securities‘s price objective suggests a potential upside of 30.87% from the company’s current price.
Several other equities research analysts have also weighed in on DLB. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Weiss Ratings raised shares of Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, September 9th. Finally, Zacks Research raised shares of Dolby Laboratories from a “strong sell” rating to a “hold” rating in a report on Friday. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $85.00.
Check Out Our Latest Report on Dolby Laboratories
Dolby Laboratories Price Performance
Dolby Laboratories stock opened at $61.13 on Monday. The company’s 50 day simple moving average is $60.97 and its 200 day simple moving average is $59.43. Dolby Laboratories has a fifty-two week low of $48.26 and a fifty-two week high of $69.95. The firm has a market capitalization of $5.73 billion, a price-to-earnings ratio of 26.01 and a beta of 0.79.
Dolby Laboratories declared that its board has initiated a share buyback program on Thursday, July 30th that permits the company to repurchase $350 million in outstanding shares. This buyback authorization permits the electronics maker to reacquire up to 7% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s management believes its stock is undervalued.
Insider Activity
In other Dolby Laboratories news, SVP John Couling sold 7,667 shares of Dolby Laboratories stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $58.78, for a total value of $450,666.26. Following the sale, the senior vice president owned 166,803 shares of the company’s stock, valued at $9,804,680.34. This trade represents a 4.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Ryan Nicholson sold 1,183 shares of the business’s stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $65.28, for a total value of $77,226.24. Following the completion of the sale, the chief accounting officer owned 34,453 shares in the company, valued at approximately $2,249,091.84. This trade represents a 3.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 16,517 shares of company stock worth $995,963 in the last three months. Company insiders own 37.93% of the company’s stock.
Institutional Trading of Dolby Laboratories
Hedge funds and other institutional investors have recently modified their holdings of the stock. Greenwich Wealth Management LLC acquired a new position in shares of Dolby Laboratories in the third quarter valued at $217,000. Lighthouse Investment Partners LLC bought a new stake in shares of Dolby Laboratories during the 3rd quarter worth about $407,000. Worldquant Millennium Advisors LLC boosted its holdings in shares of Dolby Laboratories by 248.7% during the 3rd quarter. Worldquant Millennium Advisors LLC now owns 229,035 shares of the electronics maker’s stock worth $13,460,000 after buying an additional 163,355 shares during the period. Caxton Associates LLP bought a new stake in shares of Dolby Laboratories during the 3rd quarter worth about $3,881,000. Finally, PEAK6 LLC acquired a new position in Dolby Laboratories in the 3rd quarter valued at about $1,333,000. Institutional investors and hedge funds own 58.56% of the company’s stock.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.
See Also
- Five stocks we like better than Dolby Laboratories
- MongoDB’s Biggest Advantage May Be GitLab’s Biggest Weakness
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
